UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000038969
Receipt No. R000044442
Scientific Title Effect of frailty on postoperative pain after robot-assisted laparoscopic prostatectomy: prospective observational study(FRAP trial)
Date of disclosure of the study information 2019/12/25
Last modified on 2022/12/05 (Ver. 21)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effect of frailty on postoperative pain after robot-assisted laparoscopic prostatectomy: prospective observational study(FRAP trial)
Acronym Effect of frailty on postoperative pain after robot-assisted laparoscopic prostatectomy: prospective observational study(FRAP trial)
Scientific Title Effect of frailty on postoperative pain after robot-assisted laparoscopic prostatectomy: prospective observational study(FRAP trial)
Scientific Title:Acronym Effect of frailty on postoperative pain after robot-assisted laparoscopic prostatectomy: prospective observational study(FRAP trial)
Region
Japan

Condition
Condition prostate cancer
Classification by specialty
Urology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To investigate the association between the frailty and postoperative pain in patients with prostate cancer.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The primary purpose was the effect of G8 =<14, sFI, postoperative complications, and use of analgesics on moderate-to-severe pain (NRS >=5) after RARP.
Key secondary outcomes The secondary purpose was the association of G8 =<14 with sFI, postoperative complications, and analgesics.
Exploratory purposes included 1) the association of frailty and time-dependent change of NRS, 2) the association of the maximum pain and sum of NRS, and 3) the optimal cutoff value evaluation of G8 score for NRS >=5 using receiver operating characteristic (ROC) curve.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
100 years-old >
Gender Male
Key inclusion criteria Localized prostate cancer (PC) patients who underwent robotic-radical prostatectomy (RARP)
Key exclusion criteria 1) Localized prostate cancer patients who underwent open prostatectomy and 2) who did not answered NRS after RARP
Target sample size 150

Research contact person
Name of lead principal investigator
1st name Shingo
Middle name
Last name Hatakeyama
Organization Dept. of Urology, Hirosaki University Graduate School of Medicine
Division name Urology
Zip code 036-8562
Address 5 Zaifu-chou, Hirosaki
TEL 0172395091
Email shingoh@hirosaki-u.ac.jp

Public contact
Name of contact person
1st name Shingo
Middle name Hatakeyama
Last name Hatakeyama
Organization Dept. of Urology, Hirosaki University Graduate School of Medicine
Division name Urology
Zip code 036-8562
Address 5 Zaifu-chou, Hirosaki
TEL 0172395091
Homepage URL
Email shingoh@hirosaki-u.ac.jp

Sponsor
Institute Dept. of Urology, Hirosaki University Graduate School of Medicine
Institute
Department

Funding Source
Organization Dept. of Urology, Hirosaki University Graduate School of Medicine
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Hirosaki University Graduate School of Medicine
Address 5 Zaifu-chou, Hirosaki, Japan
Tel 0172395091
Email rinri@hirosaki-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions Hirosaki University Hospital

Other administrative information
Date of disclosure of the study information
2019 Year 12 Month 25 Day

Related information
URL releasing protocol https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988788/
Publication of results Published

Result
URL related to results and publications https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988788/
Number of participants that the trial has enrolled 154
Results Frailty was significantly associated with moderate to severe pain after RARP, and might be a potential predictor of postoperative pain. Frail patients require individual care to avoid painful experiences.
Results date posted
2022 Year 12 Month 05 Day
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics To investigate the association of pain with frailty in patients with localized prostate cancer (PC) who underwent robot-assisted laparoscopic radical prostatectomy (RARP).
Participant flow Between January 2017 and June 2019, we prospectively evaluated the geriatric 8 (G8) score, simplified frailty index (sFI), and numerical rating scale (NRS) of 154 patients with localized PC who underwent RARP at our institution. NRS was measured on preoperative day 0, postoperative days 1, 2, 3, and at discharge. Moderate to severe pain was defined as NRS>=5, whereas frailty was defined as G8<=14.
Adverse events none
Outcome measures The primary objectives of this study were to investigate the effects of moderate to severe pain (NRS>=5) on frailty, postoperative complications, and the use of analgesics after RARP. Our secondary objectives were the effect of frailty on postoperative complications and the use of analgesics.
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2017 Year 01 Month 06 Day
Date of IRB
2017 Year 01 Month 06 Day
Anticipated trial start date
2017 Year 01 Month 06 Day
Last follow-up date
2022 Year 12 Month 05 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Accounting for 15% withdrawal rate, we planned to enroll 180 patients within 30 months based on the annual number of RARP in our hospital. No statistical sample size calculation was performed because of no previous evidences for the effect of frailty on postoperative pain.

Management information
Registered date
2019 Year 12 Month 24 Day
Last modified on
2022 Year 12 Month 05 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044442